Blue Biotechnology
This fifth volume in the Commonwealth Blue Economy Series, Blue Biotechnology, provides a high-level assessment of the opportunities available for economic diversification through the development of a blue biotechnology sector in SIDS for food, health products and pharmaceuticals. It examines relevant examples from around the world, and outlines specific enabling conditions that could assist in moving such a blue biotechnology sector towards becoming an economic reality where opportunities exist.
Contents
Acronyms and Abbreviations
Summary
1 Introduction
1.1 Developing a blue economy
1.2 Blue biotechnology
References
2. Blue Biotechnology: A Rapidly Developing and Evolving Sector of the Blue Economy
2.1 Blue biotechnology assets
2.2 Bioprospecting and blue biotechnology beyond pharma
Endnotes
Reference
3 Options and Technologies for Blue Biotechnology
3.1 Blue biotechnology: opportunities across the value pyramid
3.2 Fucodian: An example of commercial potential
Endnotes
References
4 Enabling Conditions
4.1 Ownership of biological resources
4.2 Bioprospecting options
4.3 Facilitation of research and entrepreneurship
4.4 Developing a centralised biological resource centre
4.5 The SIDS’ brand
References
5 Conclusion and Recommendations
5.1 Conclusions
5.2 Recommendations for fostering the development of blue biotechnology
5.3 Blue economy implementation
Reference
Glossary
Browse subjects
- Agriculture Expand or collapse me
- Democracy and elections Expand or collapse me
- Debt and finance policy
- Economic development Expand or collapse me
- Education, gender and health Expand or collapse me
- Law and human rights Expand or collapse me
- Oceans and natural resources Expand or collapse me
- Public administration and governance Expand or collapse me
- Small states Expand or collapse me
- Sport for development and peace
- Taxation
- Trade Expand or collapse me
- Youth policy
